Brain STimulation for ANxiety and Depression in Youth

Recruiting now · Not applicable

Conditions studied: Anxiety Disorders, Depression

In brief

In this open-label trial, the overall aim is to determine if TMS treatment can improve anxiety and depression in a broad group of children and youth referred by physicians.

Key facts

Study ID

NCT06892847

Run by

University of Calgary

People needed

120

Starts

2025-07-01

Expected to finish

2028-12-31

Last updated by the study team

2026-01-29

Who can join

Age: 6 and older, up to 18. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• aged between 6 and 18 years old
• diagnosis of anxiety or depression made by a qualified medical professional
• active anxiety and/or depression symptoms

You may not qualify if…

• status epilepticus in past 12-months
• presence of any disease, medical condition, or physical condition that, in the opinion of the study investigator may compromise, interfere, limit, affect, or reduce the participant's ability to complete the study
• hospitalization for suicide attempt within the past 3 months (unless participant is under the daily supervision of a physician, such as in a mental health day treatment program)
• TMS-related contraindications, including implanted medical devices (e.g., pacemaker)
• if actively taking prescription medication, no changes in medication for at least 3 months prior to entry into the study, with no anticipation of change in the frequency or dose over the duration of the study, unless changes to medication are required for participant safety
• unable to understand instructions in English

Where it is running

• Alberta Children's Hospital — Calgary, Alberta, Canada (enrolling)

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.